Myeloperoxidase and its contributory role in inflammatory vascular disease.

[1]  Denise Lau,et al.  Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[2]  R. Heller,et al.  2-Chlorohexadecanal Derived From Hypochlorite-Modified High-Density Lipoprotein–Associated Plasmalogen Is a Natural Inhibitor of Endothelial Nitric Oxide Biosynthesis , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[3]  A. Chait,et al.  Human Atherosclerotic Intima and Blood of Patients with Established Coronary Artery Disease Contain High Density Lipoprotein Damaged by Reactive Nitrogen Species* , 2004, Journal of Biological Chemistry.

[4]  T. Meinertz,et al.  Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion. , 2004, Free radical biology & medicine.

[5]  A. Chait,et al.  The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Michael Kinter,et al.  Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. , 2004, The Journal of clinical investigation.

[7]  B. Hyman,et al.  Neuronal expression of myeloperoxidase is increased in Alzheimer's disease , 2004, Journal of neurochemistry.

[8]  S. Hazen.  Myeloperoxidase and plaque vulnerability. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[9]  A. Malik,et al.  Albumin mediates the transcytosis of myeloperoxidase by means of caveolae in endothelial cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. Weisel,et al.  Pro-thrombotic State Induced by Post-translational Modification of Fibrinogen by Reactive Nitrogen Species* , 2004, Journal of Biological Chemistry.

[11]  W. Cayley.  Prognostic value of myeloperoxidase in patients with chest pain. , 2004, The New England journal of medicine.

[12]  Chunxiang Zhang,et al.  Interaction of myeloperoxidase with vascular NAD(P)H oxidase-derived reactive oxygen species in vasculature: implications for vascular diseases. , 2003, American journal of physiology. Heart and circulatory physiology.

[13]  B. Freeman,et al.  NO-dependent protein nitration: a cell signaling event or an oxidative inflammatory response? , 2003, Trends in biochemical sciences.

[14]  E. Topol,et al.  Prognostic value of myeloperoxidase in patients with chest pain. , 2003, The New England journal of medicine.

[15]  C. Heeschen,et al.  Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary Syndromes , 2003, Circulation.

[16]  S. Hazen,et al.  Emerging role of myeloperoxidase and oxidant stress markers in cardiovascular risk assessment , 2003, Current opinion in lipidology.

[17]  C. Kallenberg,et al.  Neutrophil‐activating potential of antineutrophil cytoplasm autoantibodies , 2003, Journal of leukocyte biology.

[18]  F. Crea,et al.  Widespread coronary inflammation in unstable angina. , 2003, The New England journal of medicine.

[19]  P. Stenvinkel,et al.  A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients. , 2003, Kidney international. Supplement.

[20]  S. Hazen,et al.  Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy. , 2003, JAMA.

[21]  D. Harrison,et al.  Electron Spin Resonance Characterization of Vascular Xanthine and NAD(P)H Oxidase Activity in Patients With Coronary Artery Disease: Relation to Endothelium-Dependent Vasodilation , 2003, Circulation.

[22]  Eric J. Topol,et al.  Myeloperoxidase and Plasminogen Activator Inhibitor 1 Play a Central Role in Ventricular Remodeling after Myocardial Infarction , 2003, The Journal of experimental medicine.

[23]  T. Ogino,et al.  Physiological Oxidants Induce Apoptosis and Cell Cycle Arrest in a Multidrug-resistant Natural Killer Cell Line, NK-YS , 2003, Leukemia & lymphoma.

[24]  D. Harrison,et al.  Vascular Oxidative Stress and Endothelial Dysfunction in Patients With Chronic Heart Failure: Role of Xanthine-Oxidase and Extracellular Superoxide Dismutase , 2002, Circulation.

[25]  Marie-Luise Brennan,et al.  Myeloperoxidase Functions as a Major Enzymatic Catalyst for Initiation of Lipid Peroxidation at Sites of Inflammation* , 2002, The Journal of Biological Chemistry.

[26]  C. B. Alexander,et al.  Spatial mapping of pulmonary and vascular nitrotyrosine reveals the pivotal role of myeloperoxidase as a catalyst for tyrosine nitration in inflammatory diseases. , 2002, Free radical biology & medicine.

[27]  Chunxiang Zhang,et al.  Myeloperoxidase, a Leukocyte-Derived Vascular NO Oxidase , 2002, Science.

[28]  Rainer Hambrecht,et al.  Effects of Xanthine Oxidase Inhibition With Allopurinol on Endothelial Function and Peripheral Blood Flow in Hyperuricemic Patients With Chronic Heart Failure: Results From 2 Placebo-Controlled Studies , 2002, Circulation.

[29]  Marie-Luise Brennan,et al.  A Tale of Two Controversies , 2002, The Journal of Biological Chemistry.

[30]  Robert M. Stahl,et al.  Global changes in gene expression by human polymorphonuclear leukocytes during receptor-mediated phagocytosis: Cell fate is regulated at the level of gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[31]  D. Bullard,et al.  Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration. , 2001, The Journal of clinical investigation.

[32]  C. Savage,et al.  Antineutrophil cytoplasmic antibodies stabilize adhesion and promote migration of flowing neutrophils on endothelial cells. , 2001, Arthritis and rheumatism.

[33]  J. Heinecke,et al.  Immunohistochemical detection of myeloperoxidase and its oxidation products in Kupffer cells of human liver. , 2001, The American journal of pathology.

[34]  E J Topol,et al.  Association between myeloperoxidase levels and risk of coronary artery disease. , 2001, JAMA.

[35]  W. Parks,et al.  Hypochlorous Acid Oxygenates the Cysteine Switch Domain of Pro-matrilysin (MMP-7) , 2001, The Journal of Biological Chemistry.

[36]  C. Winterbourn,et al.  Hypochlorous acid stimulation of the mitogen-activated protein kinase pathway enhances cell survival. , 2001, Archives of biochemistry and biophysics.

[37]  G. Siest,et al.  Serum myeloperoxidase concentration in a healthy population: biological variations, familial resemblance and new genetic polymorphisms , 2001, European Journal of Human Genetics.

[38]  S. Matalon,et al.  Cyclophosphamide Decreases Nitrotyrosine Formation and Inhibits Nitric Oxide Production by Alveolar Macrophages in Mycoplasmosis , 2001, Infection and Immunity.

[39]  G. Rouleau,et al.  A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians. , 2001, American heart journal.

[40]  S. Barnes,et al.  l-Arginine Chlorination Products Inhibit Endothelial Nitric Oxide Production* , 2001, The Journal of Biological Chemistry.

[41]  D. Strickland,et al.  Transcytosis of Lipoprotein Lipase across Cultured Endothelial Cells Requires Both Heparan Sulfate Proteoglycans and the Very Low Density Lipoprotein Receptor* , 2001, The Journal of Biological Chemistry.

[42]  J. Crowley,et al.  Increased atherosclerosis in myeloperoxidase-deficient mice. , 2001, The Journal of clinical investigation.

[43]  S. Hazen,et al.  Nitric Oxide Is a Physiological Substrate for Mammalian Peroxidases* , 2000, The Journal of Biological Chemistry.

[44]  D. Kutter,et al.  Consequences of Total and Subtotal Myeloperoxidase Deficiency: Risk or Benefit ? , 2000, Acta Haematologica.

[45]  P. Libby.  Coronary artery injury and the biology of atherosclerosis: inflammation, thrombosis, and stabilization. , 2000, The American journal of cardiology.

[46]  H. Koyama,et al.  Differential host susceptibility to pulmonary infections with bacteria and fungi in mice deficient in myeloperoxidase. , 2000, The Journal of infectious diseases.

[47]  C. Owen,et al.  Bioactive Proteinase 3 on the Cell Surface of Human Neutrophils: Quantification, Catalytic Activity, and Susceptibility to Inhibition1 , 2000, The Journal of Immunology.

[48]  C. Cross,et al.  Myeloperoxidase and protein oxidation in cystic fibrosis. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[49]  B. Babior.  Phagocytes and oxidative stress. , 2000, The American journal of medicine.

[50]  B. Freeman,et al.  Cytochrome c Nitration by Peroxynitrite* , 2000, The Journal of Biological Chemistry.

[51]  G. Waeg,et al.  Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins. , 2000, European journal of biochemistry.

[52]  T. Kodama,et al.  Role of myeloperoxidase in the neutrophil-induced oxidation of low density lipoprotein as studied by myeloperoxidase-knockout mouse. , 2000, Journal of biochemistry.

[53]  S. Hussain,et al.  Role of poly-(ADP-ribose) synthetase in lipopolysaccharide-induced vascular failure and acute lung injury in pigs. , 2000, Journal of critical care.

[54]  S. Hazen,et al.  Nitric Oxide Modulates the Catalytic Activity of Myeloperoxidase* , 2000, The Journal of Biological Chemistry.

[55]  C. Savage,et al.  Pathogenesis of ANCA‐associated systemic vasculitis , 2000, The Journal of pathology.

[56]  Y. Shinohara,et al.  Nitrotyrosine generation via inducible nitric oxide synthase in vascular wall in focal ischemia-reperfusion , 2000, Brain Research.

[57]  S. Hazen,et al.  Leukocytes utilize myeloperoxidase-generated nitrating intermediates as physiological catalysts for the generation of biologically active oxidized lipids and sterols in serum. , 1999, Biochemistry.

[58]  S. Hazen,et al.  Formation of nitric oxide-derived oxidants by myeloperoxidase in monocytes: pathways for monocyte-mediated protein nitration and lipid peroxidation In vivo. , 1999, Circulation research.

[59]  S. Hazen,et al.  Eosinophil Peroxidase Nitrates Protein Tyrosyl Residues , 1999, The Journal of Biological Chemistry.

[60]  T. Evans,et al.  Oxidative damage to proteins of bronchoalveolar lavage fluid in patients with acute respiratory distress syndrome: evidence for neutrophil-mediated hydroxylation, nitration, and chlorination. , 1999, Critical care medicine.

[61]  M. Lamy,et al.  Neutrophil myeloperoxidase revisited: it's role in health and disease , 1999 .

[62]  C. Schöneich,et al.  Protein modification during biological aging: selective tyrosine nitration of the SERCA2a isoform of the sarcoplasmic reticulum Ca2+-ATPase in skeletal muscle. , 1999, The Biochemical journal.

[63]  B. Freeman,et al.  Microtubule dysfunction by posttranslational nitrotyrosination of alpha-tubulin: a nitric oxide-dependent mechanism of cellular injury. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[64]  S. Hazen,et al.  Modification of type III VLDL, their remnants, and VLDL from ApoE-knockout mice by p-hydroxyphenylacetaldehyde, a product of myeloperoxidase activity, causes marked cholesteryl ester accumulation in macrophages. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[65]  K. Clouse,et al.  Human immunodeficiency virus-1-infected macrophages induce inducible nitric oxide synthase and nitric oxide (NO) production in astrocytes: astrocytic NO as a possible mediator of neural damage in acquired immunodeficiency syndrome. , 1999, Blood.

[66]  A. Kettle,et al.  Hypochlorous acid activates the tumor suppressor protein p53 in cultured human skin fibroblasts. , 1998, Archives of biochemistry and biophysics.

[67]  S. George.  Tissue inhibitors of metalloproteinases and metalloproteinases in atherosclerosis. , 1998, Current opinion in lipidology.

[68]  M. K. Magnússon,et al.  Fibronectin: structure, assembly, and cardiovascular implications. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[69]  W. Nauseef.  Insights into myeloperoxidase biosynthesis from its inherited deficiency , 1998, Journal of Molecular Medicine.

[70]  H. Ischiropoulos.  Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. , 1998, Archives of biochemistry and biophysics.

[71]  S. Michaela,et al.  Association of myeloperoxidase with heparin: Oxidative inactivation of proteins on the surface of endothelial cells by the bound enzyme , 1998, Molecular and Cellular Biochemistry.

[72]  J. Everse.  The structure of heme proteins Compounds I and II: some misconceptions. , 1998, Free radical biology & medicine.

[73]  P Lesavre,et al.  Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. , 1998, Kidney international.

[74]  R. Virmani,et al.  Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction , 1998, Heart.

[75]  Barry Halliwell,et al.  Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils , 1998, Nature.

[76]  J. K. Hurst,et al.  Relative Chlorinating, Nitrating, and Oxidizing Capabilities of Neutrophils Determined with Phagocytosable Probes* , 1997, The Journal of Biological Chemistry.

[77]  M. Auer,et al.  Transcytosis and Surface Presentation of IL-8 by Venular Endothelial Cells , 1997, Cell.

[78]  J. Christine van DALEN,et al.  Thiocyanate and chloride as competing substrates for myeloperoxidase. , 1997, The Biochemical journal.

[79]  A. Kettle,et al.  Peroxynitrite and myeloperoxidase leave the same footprint in protein nitration. , 1997, Redox report : communications in free radical research.

[80]  B. Becher,et al.  Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis , 1997, Journal of Neuroimmunology.

[81]  J. Beckman,et al.  Extensive tyrosine nitration in human myocardial inflammation: evidence for the presence of peroxynitrite. , 1997, Critical care medicine.

[82]  C. Cross,et al.  Formation of Reactive Nitrogen Species during Peroxidase-catalyzed Oxidation of Nitrite , 1997, The Journal of Biological Chemistry.

[83]  F. Hsu,et al.  Mass Spectrometric Quantification of Markers for Protein Oxidation by Tyrosyl Radical, Copper, and Hydroxyl Radical in Low Density Lipoprotein Isolated from Human Atherosclerotic Plaques* , 1997, The Journal of Biological Chemistry.

[84]  S. L. Hazen,et al.  Reactive Nitrogen Intermediates Promote Low Density Lipoprotein Oxidation in Human Atherosclerotic Intima* , 1997, The Journal of Biological Chemistry.

[85]  J S Beckman,et al.  Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. , 1996, The American journal of physiology.

[86]  J. Thompson,et al.  Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[87]  T. Fülöp,et al.  Neutrophils obtained from obliterative atherosclerotic patients exhibit enhanced resting respiratory burst and increased degranulation in response to various stimuli. , 1996, Biochimica et biophysica acta.

[88]  E. Austin,et al.  Cis-elements in the promoter region of the human myeloperoxidase (MPO) gene. , 1996, Leukemia.

[89]  A. Orani,et al.  Serum concentrations of nitrite in patients with HIV-1 infection. , 1996, Journal of clinical pathology.

[90]  M. Currie,et al.  Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators. , 1996, The Journal of clinical investigation.

[91]  R. Virmani,et al.  Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. , 1996, Circulation.

[92]  D. Roos,et al.  Effect of tumor necrosis factor-induced integrin activation on Fc gamma receptor II-mediated signal transduction: relevance for activation of neutrophils by anti-proteinase 3 or anti-myeloperoxidase antibodies. , 1995, Blood.

[93]  L. Folkes,et al.  Kinetics and mechanisms of hypochlorous acid reactions. , 1995, Archives of biochemistry and biophysics.

[94]  P. Libby,et al.  Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. , 1995, The Journal of clinical investigation.

[95]  P. Libby.  Molecular bases of the acute coronary syndromes. , 1995, Circulation.

[96]  A. Daugherty,et al.  Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. , 1994, The Journal of clinical investigation.

[97]  P. Cleary,et al.  M12 protein from Streptococcus pyogenes is a receptor for immunoglobulin G3 and human albumin , 1994, Infection and immunity.

[98]  H. Dunford,et al.  Spectral and kinetic studies on the formation of myeloperoxidase compounds I and II: roles of hydrogen peroxide and superoxide. , 1994, Biochemistry.

[99]  P G Anderson,et al.  Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. , 1994, Biological chemistry Hoppe-Seyler.

[100]  J. Stamler,et al.  Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[101]  R. Hammer,et al.  Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. , 1993, The Journal of clinical investigation.

[102]  S. Moncada,et al.  Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. , 1992, Annals of the rheumatic diseases.

[103]  R. Fenna,et al.  X-ray crystal structure of canine myeloperoxidase at 3 A resolution. , 1992, Journal of molecular biology.

[104]  R J Falk,et al.  Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[105]  H. Dunford,et al.  Reaction of compound III of myeloperoxidase with ascorbic acid. , 1990, The Journal of biological chemistry.

[106]  H. V. Van Wart,et al.  Kinetic studies on the reaction of compound II of myeloperoxidase with ascorbic acid. Role of ascorbic acid in myeloperoxidase function. , 1990, The Journal of biological chemistry.

[107]  K. L. Taylor,et al.  Assembly of dimeric myeloperoxidase during posttranslational maturation in human leukemic HL-60 cells. , 1990, Biochemistry.

[108]  H. Fliss.  Oxidation of proteins in rat heart and lungs by polymorphonuclear leukocyte oxidants , 1988, Molecular and Cellular Biochemistry.

[109]  U. Specks,et al.  Anti-neutrophil cytoplasmic autoantibodies. , 1988 .

[110]  Carl W. Miller,et al.  Regulation of gene expression of myeloperoxidase during myeloid differentiation , 1988, Journal of cellular physiology.

[111]  R. Falk,et al.  Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. , 1988, The New England journal of medicine.

[112]  S. Weiss,et al.  Proteolytic inactivation of alpha-1-proteinase inhibitor by a neutrophil metalloproteinase. , 1988, The Journal of clinical investigation.

[113]  I. Olsson,et al.  Myeloperoxidase precursors incorporate heme. , 1987, The Journal of biological chemistry.

[114]  R. Locksley,et al.  Loss of granule myeloperoxidase during in vitro culture of human monocytes correlates with decay in antiprotozoa activity. , 1987, The American journal of tropical medicine and hygiene.

[115]  J. M. Kinkade,et al.  Processing of a newly identified intermediate of human myeloperoxidase in isolated granules occurs at neutral pH. , 1986, The Journal of biological chemistry.

[116]  C. Winterbourn.  Comparative reactivities of various biological compounds with myeloperoxidase-hydrogen peroxide-chloride, and similarity of the oxidant to hypochlorite. , 1985, Biochimica et biophysica acta.

[117]  H. Koeffler,et al.  Myeloperoxidase: its structure and expression during myeloid differentiation. , 1985, Blood.

[118]  G. Vercellotti,et al.  Inflamed fibronectin: an altered fibronectin enhances neutrophil adhesion , 1983 .

[119]  J. Metcalf,et al.  Role of myeloperoxidase in the respiratory burst of human neutrophils. , 1983, Blood.

[120]  C. Nathan,et al.  Hydrogen peroxide metabolism in human monocytes during differentiation in vitro. , 1981, The Journal of clinical investigation.

[121]  R. Wever,et al.  Spectral properties of myeloperoxidase and its ligand complexes. , 1981, Biochimica et biophysica acta.

[122]  D. Roos,et al.  Characterization and quantification of the peroxidase in human monocytes. , 1978, Biochimica et biophysica acta.

[123]  R. Jandl,et al.  Termination of the respiratory burst in human neutrophils. , 1978, The Journal of clinical investigation.

[124]  P. Rausch,et al.  Granule enzymes of polymorphonuclear neutrophils: A phylogenetic comparison. , 1975, Blood.

[125]  R. Robbins,et al.  Reactive oxygen and nitrogen metabolites modulate fibronectin-induced fibroblast migration in vitro. , 2001, Free radical biology & medicine.

[126]  F. Shabani,et al.  The oxidative inactivation of tissue inhibitor of metalloproteinase-1 (TIMP-1) by hypochlorous acid (HOCI) is suppressed by anti-rheumatic drugs. , 1998, Free radical research.

[127]  M. Vissers,et al.  Hypochlorous acid disrupts the adhesive properties of subendothelial matrix. , 1997, Free radical biology & medicine.

[128]  K. L. Taylor,et al.  Isolation and identification of a protoheme IX derivative released during autolytic cleavage of human myeloperoxidase. , 1995, Archives of biochemistry and biophysics.

[129]  R. Fenna,et al.  Structure of the green heme in myeloperoxidase. , 1995, Archives of biochemistry and biophysics.

[130]  S. Kawano,et al.  Suppression of gene expression of myeloperoxidase (MPO) by γ-interferon (IFN-γ) in HL60 cells , 1993 .

[131]  J. K. Hurst,et al.  Leukocytic oxygen activation and microbicidal oxidative toxins. , 1989, Critical reviews in biochemistry and molecular biology.

[132]  H. Rosen,et al.  [52] Antimicrobial activity of myeloperoxidase , 1984 .